Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
This study has been withdrawn prior to enrollment.
University of Medicine and Dentistry of New Jersey
Information provided by:
Rutgers, The State University of New Jersey
First received: July 12, 2005
Last updated: May 22, 2015
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||July 2005|
|Primary Completion Date:||July 2005 (Final data collection date for primary outcome measure)|